Tanya Hansalik
Stock Analyst at UBS
(2.16)
# 3,041
Out of 4,429 analysts
52
Total ratings
46.2%
Success rate
1.6%
Average return
Main Sectors:
Stocks Rated by Tanya Hansalik
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: SFZN Siegfried Holding AG | Downgraded: Hold | CHF 120.00 → CHF 80.00 | $67.95 | +17.73% | 9 | Jun 16, 2026 | |
| SWX: BANB Bachem Holding AG | Maintained: Buy | CHF 80.00 | $67.95 | +17.73% | 9 | Jun 8, 2026 | |
| SWX: PPGN PolyPeptide Group AG | Maintained: Buy | CHF 40.00 | $39.35 | +1.65% | 14 | May 7, 2026 | |
| SWX: SKAN SKAN Group AG | Rated: Buy | CHF 75.00 → CHF 65.00 | $49.30 | +31.85% | 5 | Mar 26, 2026 | |
| SWX: MED Medartis Holding AG | Maintained: Hold | CHF 92.00 → CHF 87.00 | $74.10 | +17.41% | 4 | Mar 24, 2026 | |
| SWX: DESN Dottikon ES Holding AG | Maintained: Hold | CHF 365.00 | $303.50 | +20.26% | 1 | Feb 12, 2026 | |
| SWX: YPSN Ypsomed Holding AG | Reiterated: Buy | CHF 466.00 → CHF 410.00 | $351.00 | +16.81% | 10 | Nov 21, 2025 |
Siegfried Holding AG
Jun 16, 2026
Downgraded: Hold
Price Target: CHF 120.00 → CHF 80.00
Current: $67.95
Upside: +17.73%
Bachem Holding AG
Jun 8, 2026
Maintained: Buy
Price Target: CHF 80.00
Current: $67.95
Upside: +17.73%
PolyPeptide Group AG
May 7, 2026
Maintained: Buy
Price Target: CHF 40.00
Current: $39.35
Upside: +1.65%
SKAN Group AG
Mar 26, 2026
Rated: Buy
Price Target: CHF 75.00 → CHF 65.00
Current: $49.30
Upside: +31.85%
Medartis Holding AG
Mar 24, 2026
Maintained: Hold
Price Target: CHF 92.00 → CHF 87.00
Current: $74.10
Upside: +17.41%
Dottikon ES Holding AG
Feb 12, 2026
Maintained: Hold
Price Target: CHF 365.00
Current: $303.50
Upside: +20.26%
Ypsomed Holding AG
Nov 21, 2025
Reiterated: Buy
Price Target: CHF 466.00 → CHF 410.00
Current: $351.00
Upside: +16.81%